Inclusion Criteria:  Diagnosis of tye 2 diabetes by a health care provider, confirmed by chart review HbA1c 6.5-9% and fasting blood glucose <200 mg/dL at screening visit Body mass index (BMI) 25-45 kg/m2 Women should be postmenopausal (absence of menses for at least 1 year) Stable diabetes pharmacological regimen for at least 3 months previous to enrollment Sedentary subjects (<2 days/week of vigorous exercise) Willingness to follow up instructions provided by study team  Exclusion Criteria:  Evidence of cardiac arrhythmias, unstable angina (or other cardiac event), heart failure or stroke in the last 12 months Evidence of chronic kidney disease stage IV or V (GFR <30 mL/min) Evidence of uncontrolled hypertension, systolic blood pressure > 180 mmHg and/or diastolic blood pressure > 110 mmHg on more than 2 occasions in the past 12 months or at screening visit Diagnosis of chronic liver disease Uncontrolled thyroid dysfunction (abnormal TSH within 3 months of study enrollment) Active cancer Current use of hormone replacement therapy Excessive alcohol consumption (>14 drinks/week for men, >7 drinks/week for women) Current tobacco use Current pregnancy or intent to become pregnant during the course of the study Mobility limitations impeding walking Inability to swallow capsules Known allergies to any of the compounds in the supplement: glucosamine extract, fucoidan extract, olive extract, artichoke extract, red and white grapes extract, melon concentrate, hyaluronic acid